Lazard Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-77,200
| Closed | -$885K | – | 2535 |
|
|
2023
Q3 | $885K | Buy |
+77,200
| New | +$885K | ﹤0.01% | 1007 |
|
|
2023
Q2 | – | Sell |
-86,155
| Closed | -$2.78M | – | 2600 |
|
|
2023
Q1 | $2.78M | Buy |
+86,155
| New | +$2.78M | ﹤0.01% | 852 |
|
|
2022
Q3 | – | Sell |
-11,099
| Closed | -$153K | – | 2609 |
|
|
2022
Q2 | $153K | Sell |
11,099
-5,484
| -33% | -$75.6K | ﹤0.01% | 1358 |
|
|
2022
Q1 | $323K | Sell |
16,583
-8,465
| -34% | -$165K | ﹤0.01% | 1179 |
|
|
2021
Q4 | $408K | Buy |
+25,048
| New | +$408K | ﹤0.01% | 1140 |
|
|
2021
Q3 | – | Sell |
-592
| Closed | -$17K | – | 2325 |
|
|
2021
Q2 | $17K | Sell |
592
-10,864
| -95% | -$312K | ﹤0.01% | 1870 |
|
|
2021
Q1 | $320K | Sell |
11,456
-4,662
| -29% | -$130K | ﹤0.01% | 1042 |
|
|
2020
Q4 | $456K | Buy |
+16,118
| New | +$456K | ﹤0.01% | 992 |
|